Pancolitis a novel early complication of Alemtuzumab for MS treatment

Multiple Sclerosis and Related Disorders

Volumn 7, Issue , 2016, Pages 83-84

  Vijiaratnam, Nirosen ^a   Rath, Louise ^a   Xu, San San ^a   Skibina, Olga ^a  

^a Neuroscience Unit   (Australia)

Author keywords

Alemtuzumab; Complications; Infections; Multiple sclerosis

Indexed keywords

ALEMTUZUMAB; C REACTIVE PROTEIN; ERTAPENEM; FINGOLIMOD; HEMOGLOBIN; HYDROCORTISONE; INTERFERON BETA SERINE; MEROPENEM; NATALIZUMAB; PIPERACILLIN PLUS TAZOBACTAM; VALACICLOVIR; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ABDOMINAL CRAMP; ABDOMINAL TENDERNESS; ADULT; ADVERSE OUTCOME; ANTIBODY TITER; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEVER; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PANCOLITIS; RECTUM HEMORRHAGE; RIGOR; TACHYCARDIA; THROMBOCYTE COUNT; TREATMENT RESPONSE; COLITIS; COMPLICATION; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

ANTIBODIES, MONOCLONAL, HUMANIZED; COLITIS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 84964047942     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2016.03.014     Document Type: Article

References (3)

1. J.A. Cohen, A.J. Coles, D.L. Arnold, and et al. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial Lancet 380 2012 1819 1828
2. A.J. Coles, C.L. Twyman, D.L. Arnold, and et al. Alemtuzumab for patients with relapsing remitting multiple sclerosis after disease-modefying therapy: a randomised controlled phase 3 trail Lancet 380 2012 1829 1839
3. J. Rodriguez-Bano, L. Lopez-Cereo, M.D. Navarro, and et al. Faecal carriage of extended -spectrum B-lactamase producing Escherichia coli: prevalence, risk factors and molecular epidemiology J. Antimicrob. Chemother. 62 2008 1142 1149